Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
72 studies found for:    Narcolepsy
Show Display Options
Rank Status Study
21 Recruiting Narcolepsy - New Potential Treatment
Condition: Narcolepsy
Interventions: Device: Kinetic Oscillation Stimulation Device;   Device: Kinetic Oscillation Stimulation Device in placebo mode
22 Completed A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness
Condition: Narcolepsy
Interventions: Drug: ADX-N05;   Drug: Placebo
23 Not yet recruiting A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: JZP-110
24 Completed Provigil (Modafinil) Study by Taiwan Biotech Co.
Conditions: Narcolepsy;   Cataplexy;   Sleep Disorders;   Hypersomnolence;   Excessive Sleepiness
Intervention: Drug: Modafinil
25 Completed Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy
Conditions: Narcolepsy;   Cataplexy;   Excessive Daytime Sleepiness
Interventions: Drug: BF2.649;   Drug: BF2.649 add on Modafinil
26 Completed Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness
Condition: Narcolepsy
Intervention: Drug: Modafinil
27 Completed
Has Results
Clarithromycin for the Treatment of Hypersomnia
Conditions: Hypersomnia;   Idiopathic Hypersomnia;   Narcolepsy
Interventions: Drug: Clarithromycin followed by placebo;   Drug: Placebo then Clarithromycin
28 Unknown  Effect of Intranasal Administration of Orexine A on IL-6-System, Sleep-Wake-Regulation and Neurocognition
Condition: Narcolepsy
Intervention: Drug: Orexine A
29 Completed
Has Results
Flumazenil for the Treatment of Primary Hypersomnia
Conditions: Hypersomnia;   Primary Hypersomnia;   Idiopathic Hypersomnia;   Narcolepsy Without Cataplexy
Intervention: Drug: Flumazenil
30 Not yet recruiting A Long-Term, Open-Label Safety and Maintenance of Efficacy Study of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or Obstructive Sleep Apnea
Conditions: Narcolepsy;   Obstructive Sleep Apnea
Intervention: Drug: JZP-110
31 Completed Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Sodium Oxybate (Xyrem)
32 Active, not recruiting Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)
Conditions: Narcolepsy With Cataplexy;   Excessive Daytime Sleepiness
Interventions: Drug: Pitolisant;   Drug: Placebo
33 Recruiting Neurophysiologic Correlates of Hypersomnia
Conditions: Major Depressive Disorder;   Primary Hypersomnia;   Bipolar Disorder;   Narcolepsy;   Primary Insomnia
Intervention: Other: Acoustical slow wave induction
34 Completed Sleep Disorders of Patients With Diseases of the Nervous System
Conditions: Hypersomnia;   Narcolepsy;   Nervous System Disease;   Sleep Disorder
Intervention:
35 Enrolling by invitation Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Condition: Narcolepsy
Intervention:
36 Recruiting Amylase and Hypersomnia
Condition: Hypersomnia in Children
Intervention: Procedure: saliva collection
37 Completed Method of Assessment of Driving Ability in Patients Suffering From Wakefulness Pathologies
Conditions: Narcolepsy;   Hypersomnia
Interventions: Drug: Modafinil;   Drug: Placebo
38 Completed Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)
Condition: Narcolepsy
Intervention: Drug: BF2.649
39 Recruiting The Nuvigil and Provigil Pregnancy Registry
Conditions: Narcolepsy;   Obstructive Sleep Apnea;   Shift Work Sleep Disorder
Intervention: Drug: Modafinil/armodafinil
40 Recruiting Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study
Conditions: Obstructive Sleep Apnea of Adult;   Insomnia;   Circadian Rhythm Sleep Disorder, Unspecified Type;   Restless Legs Syndrome;   Narcolepsy and Hypersomnia
Interventions: Other: CONV care for the diagnosis and treatment of sleep disorders;   Other: PCCM for the diagnosis and treatment of sleep disorders

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years